1 / 13

Pharmacovigilance Market will Grow at a CAGR of 13% by 2020

pharmacovigilance market was valued USD 2.5 billion in 2014. The revenue of this market is projected to increase at CAGR of 13% during the forecast period.

wamy156
Download Presentation

Pharmacovigilance Market will Grow at a CAGR of 13% by 2020

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Pharmacovigilance Market Research Report Presented By Market Research Engine https://www.marketresearchengine.com/

  2. Report TitlePharmacovigilance Market will Grow at a CAGR of 13% by 2020 - by Market Research Engine

  3. New York, July 28: Market Research Engine has published a new report titled as “Pharmacovigilance Market (Phases of Drug Development: Preclinical Studies, Clinical Trial Phase I, II, III & IV or Post Marketing Surveillance; Type of Methods: Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, & EHR Mining; Type of Service: In-House & Contract Outsourcing) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020” Pharmacovigilance is associated with drug safety which involves gathering, detecting, monitoring and preventing adverse reaction of drug. It mainly focuses on adverse drug reactions. The information accumulated from healthcare providers and patients plays a significant role in pharmacovigilance to transpire. The whole purpose of pharmacovigilance is to minimize the adverse effects of drugs on the patients.  Browse Full Report https://www.marketresearchengine.com/reportdetails/pharmacovigilance-market Global pharmacovigilance market was valued USD 2.5 billion in 2014. The revenue of this market is projected to increase at CAGR of 13% during the forecast period.

  4. North America is the leading market for pharmacovigilance market globally with largest market 2014. Europe is a subsequent market owing to implementation of pharmacovigilance. Asia Pacific market is fastest growing market with highest CAGR accounted in 2014. Increasing need of pharmacovigilance owing to increasing prevalence of adverse drug reaction is a major driving factor. Rise in intricacy of drug safety regulation by government is a growth factor for this market. Growing demand in paints & coating industry is one of the driving factor.  The global pharmacovigilance market according to clinical trial phase is segmented aspre-clinical, Phase I, Phase II, Phase IIIandPhase IV. The type of service provider segment consists of In-House and contract outsourcing. The market segments in terms of geographical regions include North America, Europe, Asia-Pacific andRest of the World(ROW). This report provides:  An overview of the global market for pharmacovigilance and related technologies. 2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2020.

  5. 3) Identifications of new market opportunities and targeted promotional plans for pharmacovigilance market. 4) Discussion of research and development, and the demand for new products and new applications. 5) Comprehensive company profiles of major players in the industry. REPORT SCOPE:  The scope of the report includes a detailed study of global and regional markets for various types of coatings with the reasons given for variations in the growth of the industry in certain regions. The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market.

  6. Key players profiled in the report include: • Quintiles Transnational Corporation • Accenture Plc. • BoehringerIngelheim GmbH • Bristol-Myers Squibb • PAREXEL International Corporation • Janssen Research & Development LLC • Pharmaceutical Product Development Inc. • United BioSource Corporation • Synowlwedge LLC • Cognizant Technology Solutions Corporation • Covance Inc. • ICON, Plc. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

  7. The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.  The Pharmacovigilance Market has been segmented as below:  by Clinical Trial Phase  • Pre clinical              • Phase I             • Phase II             • Phase III             • Phase IV by Type of Service Provider              • In- House             • Contract outsourcing

  8. by Region • North America • Europe • Asia Pacific • Rest of the World (RoW) Reasons to buy this Report:  1) Obtains the most up to date information available on all active and planned pharmacovigilance industry globally. 2) Identify growth segments and opportunities in the industry. 3) Facilitate decision making on the basis of strong historic and forecast of pharmacovigilance industry and unit capacity data. 4) Assess your competitor’s refining portfolio and its evolution.

  9. Table of Contents Chapter 1 Introduction 1.1 Report Description 1.2 Research Methodology 1.3 Market Segmentation Chapter 2 Executive Summary Chapter 3 Global Pharmacovigilance Market Dynamics 3.1 Introduction 3.2 Market Drivers 3.2.1 Increasing Consumption of Drugs Would Fuel Demand for Continuous Drug Event Monitoring 3.2.2 Rise in the Cases of Adverse Drug Reactions and Drug Toxicity Would Boost Demand for Pharmacovigilance Activities 3.2.3 Rise in Adoption of Outsourcing Services Expected to Accentuate the Market Growth 3.3 Market Restraints 3.3.1 High Risk Associated with Data Security in Pharmacovigilance Outsourcing 3.3.2 Lack of Availability of Skilled Labor might Hinder the Market Growth

  10. 3.3.3 Inadequate Pharmacovigilance System for Herbal Products in Asia Pacific Might Hamper the Market Growth 3.4 Market Opportunities 3.4.1 Huge Scope for Rapid Growth of Pharmacovigilance Market in Emerging Economies 3.4.2 Shift in Preference for Outsourcing among Various Pharmaceutical and Life Sciences Companies 3.5 Porter’s Five Forces Analysis: Global Pharmacovigilance Market 3.5.1 Bargaining Power of Suppliers 3.5.2 Bargaining Power of Buyers 3.5.3 Threat of Substitutes 3.5.4 Threat of New Entrants 3.5.5 Competitive Rivalry 3.6 Market Attractiveness Analysis: Global Pharmacovigilance Market, by Geography 3.7 Competitive Landscape 3.7.1 Market Share Analysis: Global Pharmacovigilance Market, 2013 (Value %) Chapter 4 Global Pharmacovigilance Market, by Phases of Drug Development 4.1 Overview 4.1.1 Global Pharmacovigilance Market Revenue, by Phases of Drug Development, 2012 – 2020 (USD Million) 4.1.2 Comparative Analysis: Global Pharmacovigilance Market Revenue, by Type of Clinical Trial Phases, 2013 & 2020 (Value %) 4.2 Preclinical Studies 4.2.1 Global Preclinical Studies Pharmacovigilance Market Revenue, 2012 – 2020 (USD Million) 4.3 Phase I

  11. 4.3.1 Global Phase I Clinical Trial Pharmacovigilance Market Revenue, 2012 – 2020 (USD Million) 4.4 Phase II 4.4.1 Global Phase II Clinical Trial Pharmacovigilance Market Revenue, 2012 – 2020 (USD Million) 4.5 Phase III 4.5.1 Global Phase III Clinical Trial Pharmacovigilance Market Revenue, 2012 – 2020 (USD Million) 4.6 Phase IV or Post Marketing Surveillance 4.6.1 Global Phase IV Clinical Trial Pharmacovigilance Market Revenue, 2012 – 2020 (USD Million) Chapter 5 Global Pharmacovigilance Market, By Type of Methods 5.1 Overview 5.1.1 Global Pharmacovigilance Market Revenue, by Type of Methods , 2012 – 2020 (USD Million) 5.1.2 Comparative Analysis: Global Pharmacovigilance Market Revenue, by Type of Methods, 2013 & 2020 (Value %) 5.3 Spontaneous Reporting 5.3.1 Global Spontaneous Reporting Market Revenue, 2012 – 2020 (USD Million) 5.4 Intensified ADR Reporting 5.4.1 Global Intensified ADR Reporting Market Revenue, 2012 – 2020 (USD Million) 5.5 Targeted Spontaneous Reporting 5.5.1 Global Targeted Spontaneous Reporting Market Revenue, 2012 – 2020 (USD Million) 5.6 Cohort Event Monitoring 5.6.1 Global Cohort Event Monitoring Market Revenue, 2012 – 2020 (USD Million) 5.7 EHR Mining 5.7.1 Global EHR Mining Market Revenue, 2012 – 2020 (USD Million)

  12. Check out other Research Reports: Magnesium Oxide Nanopowder Market for Furnaces & Boilers, Paints & Coatings, Electronics, Electrical, Construction, and Other End-users - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 https://www.marketresearchengine.com/reportdetails/magnesium-oxide-nanopowder-market Specialty Enzymes Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2015 - 2020 https://www.marketresearchengine.com/reportdetails/speciality-enzymes-market

  13. About Market Research Engine Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies. More info: https://www.marketresearchengine.com/ Media Contact: Name: John Bay Toll Free No.: +1-855-984-1862 Phone: +91-860-565-7204 Email:john@marketresearchengine.com Website:https://www.marketresearchengine.com/

More Related